InvestorsHub Logo
Followers 61
Posts 8290
Boards Moderated 1
Alias Born 10/30/2015

Re: QL300 post# 553882

Thursday, 12/29/2022 3:54:12 PM

Thursday, December 29, 2022 3:54:12 PM

Post# of 716104
The technical matter may be moot for commercial reasons. If Merck wants to combine DCVax with Keytruda via licensing or partnership agreements, then they have to work through NWBO.

Merck and NWBO have known each other for years. They (Merck) were also guests at the NYAS presentation back in May. Almost impossible they’ve waited until just now to hold talks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News